scispace - formally typeset
G

Georg Zeller

Researcher at European Bioinformatics Institute

Publications -  95
Citations -  14859

Georg Zeller is an academic researcher from European Bioinformatics Institute. The author has contributed to research in topics: Microbiome & Metagenomics. The author has an hindex of 39, co-authored 79 publications receiving 10892 citations. Previous affiliations of Georg Zeller include Max Planck Society & Memorial Sloan Kettering Cancer Center.

Papers
More filters
Posted ContentDOI

SIAMCAT: user-friendly and versatile machine learning workflows for statistically rigorous microbiome analyses

TL;DR: The SIAMCAT R package is presented, a versatile and user-friendly toolbox for comparative metagenome analyses using machine learning, statistical tests, and visualization, and optimized the choice of ML algorithms and preprocessing routines for default workflow settings.
Journal ArticleDOI

Calorie restriction improves metabolic state independently of gut microbiome composition: a randomized dietary intervention trial

TL;DR: The HELENA trial as mentioned in this paper evaluated the effects of intermittent calorie restriction (ICR) operationalized as the 5:2 diet versus continuous calorie restriction on fecal microbiota of 147 overweight or obese adults in a 50-week parallel-arm randomized controlled trial.
Journal ArticleDOI

Calorie restriction improves metabolic state independently of gut microbiome composition: a randomized dietary intervention trial

TL;DR: The HELENA trial as discussed by the authors evaluated the effects of intermittent calorie restriction (ICR) operationalized as the 5:2 diet versus continuous calorie restriction on fecal microbiota of 147 overweight or obese adults in a 50-week parallel-arm randomized controlled trial, the HELENA Trial.
Posted ContentDOI

Extensive Transmission of Microbes along the Gastrointestinal Tract

TL;DR: Evidence is found for a vast majority of oral species to be transferable, with increased levels of transmission in colorectal cancer and rheumatoid arthritis patients and, more generally, for species described as opportunistic pathogens.